| Authors | Magnus Tobiasson, Tatjana Pandzic, Lucia Cavelier, Birgitta Sander, Björn Engelbrekt Wahlin |
| Journal | Leukemia & lymphoma
(Leuk Lymphoma)
Vol. 60
Issue 13
Pg. 3316-3319
(12 2019)
ISSN: 1029-2403 [Electronic] United States |
| PMID | 31204875
(Publication Type: Case Reports, Letter)
|
| Chemical References |
- Antimetabolites, Antineoplastic
- CUX1 protein, human
- DNA-Binding Proteins
- DNMT3A protein, human
- Homeodomain Proteins
- Proto-Oncogene Proteins
- Repressor Proteins
- Transcription Factors
- Vincristine
- Doxorubicin
- Cyclophosphamide
- Dioxygenases
- TET2 protein, human
- DNA (Cytosine-5-)-Methyltransferases
- DNA Methyltransferase 3A
- Azacitidine
- Prednisone
|
| Topics |
- Aged, 80 and over
- Antimetabolites, Antineoplastic
(pharmacology, therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology, therapeutic use)
- Azacitidine
(pharmacology, therapeutic use)
- Bone Marrow
(drug effects, pathology)
- Cyclophosphamide
(pharmacology, therapeutic use)
- DNA (Cytosine-5-)-Methyltransferases
(genetics)
- DNA Methylation
(drug effects)
- DNA Methyltransferase 3A
- DNA-Binding Proteins
(genetics)
- Dioxygenases
- Doxorubicin
(pharmacology, therapeutic use)
- Drug Resistance, Neoplasm
(genetics)
- Female
- Homeodomain Proteins
(genetics)
- Humans
- Immunoblastic Lymphadenopathy
(diagnosis, drug therapy, genetics)
- Lymph Nodes
(drug effects, pathology)
- Lymphoma, T-Cell
(diagnosis, drug therapy, genetics)
- Mutation
- Myelodysplastic Syndromes
(drug therapy, genetics)
- Prednisone
(pharmacology, therapeutic use)
- Proto-Oncogene Proteins
(genetics)
- Repressor Proteins
(genetics)
- Transcription Factors
(genetics)
- Treatment Outcome
- Vincristine
(pharmacology, therapeutic use)
|
